Israeli Electrode Could Aid Stroke Victims?

This miniature device may be the difference between a stroke victim walking away normally or suffering a disability for the rest of their life.

(Israel21c) The main problem in treating strokes has been the inability of effective drug delivery to the brain due to a mechanism called the "blood brain barrier," which prevents large-molecule drugs from entering the central nervous system (CNS).

A procedure developed by an Israel company, Brainsgate solves this life-threatening problem by stimulating the CNS' main nerve center - the spheno-palatine ganglion (SPG) - to increase blood flow to the brain. Called the Neuropath System, the technology is based on a miniature electrode implanted on the roof of the mouth within 24 hours following a stroke.

This technology is already being tested in India, Germany, Hungary, Israel and soon in America. The beautiful thing about this is that it is both simple and effective. The company even won an award for their idea, although CEO Avinoam Dayan seems to be shy of the spotlight (although it will help his company grow).

Hopefully this product will receive FDA approval in the next few years, and I would not be surprised to see this product become popular within the elderly community worldwide.

Want more good news about Israel?

Enter your email address below to subscribe!

Enter your email address:

Delivered by FeedBurner

Have a feed reader? Subscribe via RSS or Atom.